LTFS
FSTX

Ladenburg Thalmann Financial Services’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-125
Closed -$5K – 5478
2019
Q1 		$5K Sell
125
-25
-17% -$1.05K ﹤0.01% 4695
2018
Q4 		$6K Hold
150
– – ﹤0.01% 4538
2018
Q3 		$7K Buy
150
+25
+20% +$1.25K ﹤0.01% 4477
2018
Q2 		$8K Hold
125
– – ﹤0.01% 4397
2018
Q1 		$8K Hold
125
– – ﹤0.01% 4397
2017
Q4 		$7K Hold
125
– – ﹤0.01% 4400
2017
Q3 		$8K Hold
125
– – ﹤0.01% 4198
2017
Q2 		$7K Buy
+125
New +$5.79K ﹤0.01% 4208

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FSTX Position: Q2 2019 in Review

Ladenburg Thalmann Financial Services sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2019, closing a stake of 125 shares — an estimated $5K sold.

Ladenburg Thalmann Financial Services first reported a position in FSTX in Q2 2017 and held it in 8 quarters. The position peaked at $8K in Q2 2018. 50 funds tracked by Wall St. Rank hold FSTX as of Q2 2019.

  • Ladenburg Thalmann Financial Services reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 125 F-star Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $5K.
  • Ladenburg Thalmann Financial Services first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2017 and held it in 8 quarters.
  • Ladenburg Thalmann Financial Services's F-star Therapeutics, Inc. Common Stock position peaked at $8K in Q2 2018.
  • 50 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2019, filed 15 Aug 2019.